| 注册
首页|期刊导航|中国医药科学|联合用药对重度支气管哮喘合并COPD患者的疗效及生活质量的影响

联合用药对重度支气管哮喘合并COPD患者的疗效及生活质量的影响

彭伟鹏

中国医药科学Issue(5):83-85,3.
中国医药科学Issue(5):83-85,3.

联合用药对重度支气管哮喘合并COPD患者的疗效及生活质量的影响

Impact on the efficacy and life quality of combination therapy for patients of severe bronchial asthma with COPD

彭伟鹏1

作者信息

  • 1. 广东省汕头潮南民生医院呼吸内科,广东汕头515144
  • 折叠

摘要

Abstract

ObjectiveTo investigate effect of tiotropium bromide and large dose of salmeterol xinafoate fluticasone propionate in patients with bronchial asthma combined with COPD.Methods71 patients of bronchial asthma combined with COPD were randomly divided into observation group(n=36 cases)and control group(n=35 cases). The two groups were given conventional treatment.The control group was given tiotropium bromide and moderate dose of salmeterol xinafoate fluticasone propionate,while the observation group was given tiotropium bromide and large dose of salmeterol xinafoate fluticasone propionate.Efficacy of the two groups was compared.Results ACT score of pre-treatment,and 1 month,6 month,12 month in two groups had no significant difference(P>0.05).After 1 years of treatment,FEV1% estimates,FEV1 increase,Delta PEF,acute exacerbation onset time,interval time,CAT score of observation group were significantly better than that of the control group(P<0.05).Conclusion Tiotropium bromide and large dose of salmeterol xinafoate fluticasone propionate in patients with bronchial asthma combined with COPD can significantly improve lung function,relieve the acute exacerbation of symptoms,improve the quality of life,and is worthy of promotion.

关键词

噻托溴铵/沙美特罗氟替卡松/支气管哮喘/COPD

Key words

Tiotropium bromide/Salmeterol xinafoate fluticasone propionate/Bronchial asthma/COPD

分类

医药卫生

引用本文复制引用

彭伟鹏..联合用药对重度支气管哮喘合并COPD患者的疗效及生活质量的影响[J].中国医药科学,2015,(5):83-85,3.

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文